
An artist’s rendering incorporates the images of the Müller glia-derived rod photoreceptors.Bo Chen, Ph.D.
New technique generates rod photoreceptors that integrate into the retina and brain.
Researchers funded by the National Eye Institute (NEI) have reversed congenital blindness in mice by changing supportive cells in the retina called Müller glia into rod photoreceptors. The findings advance efforts toward regenerative therapies for blinding diseases such as age-related macular degeneration and retinitis pigmentosa. A report of the findings appears online today in Nature. NEI is part of the National Institutes of Health.
“This is the first report of scientists reprogramming Müller glia to become functional rod photoreceptors in the mammalian retina,” said Thomas N. Greenwell, Ph.D., NEI program director for retinal neuroscience. “Rods allow us to see in low light, but they may also help preserve cone photoreceptors, which are important for color vision and high visual acuity. Cones tend to die in later-stage eye diseases. If rods can be regenerated from inside the eye, this might be a strategy for treating diseases of the eye that affect photoreceptors.”
Photoreceptors are light-sensitive cells in the retina in the back of the eye that signal the brain when activated. In mammals, including mice and humans, photoreceptors fail to regenerate on their own. Like most neurons, once mature they don’t divide.
Scientists have long studied the regenerative potential of Müller glia because in other species, such as zebrafish, they divide in response to injury and can turn into photoreceptors and other retinal neurons. The zebrafish can thus regain vision after severe retinal injury. In the lab, however, scientists can coax mammalian Müller glia to behave more like they do in the fish. But it requires injuring the tissue.
“From a practical standpoint, if you’re trying to regenerate the retina to restore a person’s vision, it is counterproductive to injure it first to activate the Müller glia,” said Bo Chen, Ph.D., associate professor of ophthalmology and director of the Ocular Stem Cell Program at the Icahn School of Medicine at Mount Sinai, New York.
“We wanted to see if we could program Müller glia to become rod photoreceptors in a living mouse without having to injure its retina,” said Chen, the study’s lead investigator.
In the first phase of a two-stage reprogramming process Chen’s team spurred Müller glia in normal mice to divide by injecting their eyes with a gene to turn on a protein called beta-catenin. Weeks later, they injected the mice’s eyes with factors that encouraged the newly divided cells to develop into rod photoreceptors.
The researchers used microscopy to visually track the newly formed cells. They found that the newly formed rod photoreceptors looked structurally no different from real photoreceptors. In addition, synaptic structures that allow the rods to communicate with other types of neurons within the retina had also formed. To determine whether the Müller glia-derived rod photoreceptors were functional, they tested the treatment in mice with congenital blindness, which meant that they were born without functional rod photoreceptors.
In the treated mice that were born blind, Müller glia-derived rods developed just as effectively as they had in normal mice. Functionally, they confirmed that the newly formed rods were communicating with other types of retinal neurons across synapses. Furthermore, light responses recorded from retinal ganglion cells — neurons that carry signals from photoreceptors to the brain — and measurements of brain activity confirmed that the newly-formed rods were in fact integrating in the visual pathway circuitry, from the retina to the primary visual cortex in the brain.
Chen’s lab is conducting behavioral studies to determine whether the mice have regained the ability to perform visual tasks such as a water maze task. Chen also plans to see if the technique works on cultured human retinal tissue.
Learn more: NIH-funded researchers reverse congenital blindness in mice
The Latest on: Congenital blindness
[google_news title=”” keyword=”congenital blindness” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Congenital blindness
- Congenital Stationary Night Blindness in Dogs: Symptoms, Causes, & Treatmentson September 27, 2023 at 1:19 pm
Congenital stationary night blindness in dogs is an inherited condition that affects a dog’s retina. Often, the disorder is referred to as “CSNB.” Technically, the condition is also known as ...
- Shahmeer Ul Hassan’s life changing operation to cure rare Leber’s Congenital Amaurosison September 25, 2023 at 12:37 pm
The parents of a toddler battling an extremely rare and cureless disease that could leave him permanently blind are holding on to hope as they prepare for a “life changing” operation.
- Is blindness genetic? What to knowon September 23, 2023 at 5:00 pm
Some of these causes are genetic. For example, a person may inherit a genetic condition that causes blindness from birth. This is known as congenital blindness. Alternatively, genetics can make a ...
- Rates Spike 1,000% for Infants Hospitalized With Syphilison September 21, 2023 at 2:00 pm
The number of babies hospitalized with syphilis has spiked in Mississippi, according to a study published by the Centers for Disease Control and Prevention on Wednesday. The rate increased by 1,000% ...
- Glaucoma: A Hidden Threat to Vision Health Rising Swiftlyon September 20, 2023 at 12:18 pm
It's predicted that by 2050, the number of people with glaucoma will surge by more than 200%, highlighting an urgent need for heightened awareness, early detection, and advanced treatment strategies.
- Mississippi sees 10-fold increase in babies born with syphilis since 2016: Reporton September 20, 2023 at 10:09 am
A new report found that cases of babies with congenital syphilis in Mississippi rose 10-fold between 2016 and 2022 from 10 to 110.
- Congenital Neutropenia Treatment Market Size, Share and Growth 2023|2030on September 19, 2023 at 9:51 pm
The Global Congenital Neutropenia Treatment Market is anticipated to rise at a considerable rate during the forecast period, between 2022 and 2031. In 2021, the market is growing at a steady rate ...
- ‘My baby’s big blue eyes drew endless compliments – but they were the sign of a life-changing condition’on September 18, 2023 at 3:31 am
But the family were told Aretria - now 10 months old - had a severe case of bilateral congenital glaucoma, a genetic abnormality which saw extreme and growing pressure on the optic nerve.
- Baby's big eyes were secret sign of rare cause of blindnesson September 17, 2023 at 9:27 am
A baby girl's "beautiful big blue eyes" were actually a symptom of a condition causing blindness. Aretria Bice ... 29 - were told Aretria had a severe case of bilateral congenital glaucoma - a genetic ...
via Bing News